Study guide
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting
Mississippi MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Mississippi MPJE Overview
1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight
2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure
2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring
3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority
3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security
4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols
5 Chapter 5: Dispensing Controlled Substances & Prescription Processing
5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose
6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi
7 Chapter 7: Pharmacy Operations, Permits & Facilities
7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines
8 Chapter 8: Compounding Standards, Safety & Product Selection
8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications
9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations
9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting
Key Takeaways Explain This Topic AI
Mississippi PMP rules are in Board Article XLIII, not Article XXXIII, and the program receives covered dispensing data on the schedule set by the PMP.
Current PMP guidance requires reporting no later than 24 hours after dispensing or the next business day and requires zero reports when no covered dispensing occurred.
Pharmacists must query before dispensing a Schedule II opiate to a new customer or one without an opioid fill at that pharmacy in the prior six months, and at least every six months for a patient receiving any controlled substance.
Direct administration and dispensing quantities of 48 hours or less are excluded from PMP reporting; other setting-specific reporting and exemptions must be applied exactly.
Current PMP reporting guidance includes Schedules II–V and identifies medical cannabis and gabapentin reporting; detected reporting errors must be corrected within seven days.
Last updated: August 2026
Mississippi Prescription Monitoring Program
The Mississippi Prescription Monitoring Program is administered through the Board of Pharmacy. The principal Board regulation is Article XLIII . The program collects dispensing information and provides authorized users a tool to identify controlled-substance patterns; it does not replace professional judgment or corresponding responsibility.
Reporting schedule and covered data
Current Mississippi PMP guidance requires a dispenser to submit covered data within 24 hours after dispensing or by the next business day . A dispenser that had no covered dispensing submits a zero report for the reporting period. A transmission vendor or corporate office may send the file, but the permitted dispenser remains responsible for complete and accurate reporting.
The submission includes patient or representative identity, date of birth, NDC, dispensing date, quantity, days’ supply, dispenser identifier, prescriber DEA number, payment method, and other required PMP fields. Current guidance covers Schedule II–V controlled substances and also identifies medical cannabis and gabapentin in the reporting framework. Verify the live data-submission guide when building a system because file specifications can change.
If the program identifies an error, current guidance requires correction within seven days . A rejected batch is not a successful report; monitor acknowledgments and correct demographic, NDC, prescriber, date, quantity, and identifier errors.
Reporting exclusions and settings
Article XXIII and PMP guidance exclude medication directly administered to a patient and a dispensed quantity of 48 hours or less from the ordinary outpatient reporting requirement. Do not convert “greater than a 48-hour supply is reportable” into “report every two-day supply.”
Veterinarians are excluded when they themselves dispense in the veterinary setting under the stated guidance, but a pharmacy that fills a veterinary prescription reports the pharmacy dispensing when otherwise covered. Nursing-facility, assisted-living, nonresident/mail-order, and other dispensers should apply the current program instructions; facility location alone does not erase reporting.
Pharmacist query triggers
The current pharmacist-specific query rule is more precise than “check before every prescription.” Before dispensing a Schedule II opiate , query the PMP when the person is a new customer or has not had an opioid prescription filled at that pharmacy during the prior six months . In addition, a pharmacist dispensing a controlled substance to a patient must query the PMP at least every six months .
Other facts can justify a query even when those minimum triggers do not compel one: early fills, multiple prescribers or pharmacies, overlapping sedatives, distance, cash payment, altered prescriptions, or inconsistent history. Conversely, a PMP report is only one source. Confirm identity, recognize reporting lag and errors, communicate with patient and prescriber, and document resolution of meaningful concerns.
The pharmacist should use the patient-search and delegate functions only as current PMP policy permits. Delegation of data retrieval does not transfer the pharmacist’s responsibility to interpret the report or make the dispensing decision. PMP information is confidential and accessed or disclosed only for authorized purposes; curiosity searches and sharing outside authorized care or oversight can produce discipline and other liability.
Workflow
At intake, identify whether the product and quantity are reportable and whether a pharmacist query trigger applies. Before release, resolve PMP red flags and complete corresponding responsibility. After dispensing, submit the record by the deadline, confirm acceptance, correct errors within seven days, and submit zero reports when applicable. Maintain policies for downtime, mergers, software conversion, and reverse claims so that corrections reach the PMP rather than only the local claim system.
Exam method
Separate reporting from querying . Reporting asks what the dispenser sends and when; querying asks when an authorized user must check. Remember: 24 hours/next business day, zero report, 48-hour-or-less exclusion, new/no-six-month Schedule II opiate query, every-six-month controlled-substance query, and seven-day correction .
Reporting and query examples
A pharmacy dispenses a 30-day alprazolam prescription: it is reportable, and the patient’s controlled-substance history must also satisfy the at-least-every-six-month pharmacist query rule. A one-day controlled analgesic discharge quantity is excluded by the 48-hour-or-less reporting provision, but corresponding responsibility and any query triggered by the facts still apply. Reporting exclusion does not mean dispensing exemption.
If the pharmacy reverses a claim after the patient never picks up the medication, correct the PMP transaction through the current submission process. A local claim reversal that never reaches the PMP leaves inaccurate history. Review acceptance and rejection files daily, file zero reports for empty periods, and correct identified errors within seven days.
Loading diagram... 6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting — Current Rule Map